← All companies

ENVB

Enveric Biosciences, Inc.

ENVB Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.60

+0.03 +1.91%

Key statistics

from XBRL data in SEC filings

Market cap

$5.89M

Revenue (TTM)

$35.4M

Net income (TTM)

$12.7M

EPS (TTM)

$-22.74

P/E ratio

—

Dividend yield

—

Free cash flow

-$8.15M

Cash

$1.58M

Total assets

$5.52M

Gross margin

20.7%

52-week range

$1.25 – $17.64

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jun 9, 2026 8-K Regulation FD disclosure Jun 9, 2026 8-K Director or officer change; Shareholder vote results May 29, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 8-K Other events Apr 30, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release) Mar 27, 2026 8-K Other events Feb 6, 2026 8-K Entered a material agreement; Unregistered sale of equity Jan 28, 2026 8-K Regulation FD disclosure Jan 9, 2026 8-K Entered a material agreement; Unregistered sale of equity Dec 12, 2025 8-K Shareholder vote results Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Other events Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Delisting notice or listing-rule failure; Modified rights of security holders; Amended charter or bylaws; Other events Oct 23, 2025 8-K Entered a material agreement; Unregistered sale of equity Sep 18, 2025 8-K Regulation FD disclosure; Other events Sep 2, 2025 8-K Regulation FD disclosure Aug 29, 2025 8-K Delisting notice or listing-rule failure Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Shareholder vote results Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Changed accountants Apr 14, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Other events Mar 6, 2025 8-K Regulation FD disclosure Feb 26, 2025 8-K Entered a material agreement; Other events Feb 3, 2025 8-K/A Amended charter or bylaws Jan 27, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jan 21, 2025 8-K Regulation FD disclosure Jan 3, 2025 8-K Delisting notice or listing-rule failure Nov 22, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Entered a material agreement; Other events Nov 12, 2024